SBIR Phase I: Enhancing the Bactericidal Activity of Copper: An Economically Viable Solution for Lowering Copper Usage Rates in Agriculture
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- AGILE SCIENCES, INC.
- Proposal award date
- 2012-07-01
- Contract end date
- 2012-12-31
- UEI
- L9UJBZEVVDM1
- Solicitation number
- Not reported
- Topic code
- BC
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Small Molecule Antibiotic Potentiators for Drug-Resistant Bacteria
- Development of novel anti-biofilm compounds for treating chronic wounds
- Small molecules as antibiotic potentiating agents against multi-drug resistant Gram-negative infections
- Anti-biofilm agents for the treatment of pulmonary infection in cystic fibrosis p
- Evaluation of a new class of molecules for treating MRSA infective endocarditis
Research funding history
15 SBIR/STTR records share this UEI (2009–2016). Reported award amounts total $8,631,717. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation